​

We are an innovative drug delivery and development company that works with our partners to turn their active agents into novel therapeutic drug products. The company’s technology is based on porous silicon and encapsulation methodology, which has significant advantages over existing technologies.

​

 
COMPANY’S BUSINESS

I. Porous silicon-based drug delivery for targeted and controlled release of small molecules for biopharmaceutical partners.

 II. Developing our own pipeline of products for unmet commercial and clinical needs.